Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 164: 107896, 2020 03 01.
Article in English | MEDLINE | ID: mdl-31811875

ABSTRACT

The LPA1 receptor, one of the six characterized G protein-coupled receptors (LPA1-6) through which lysophosphatidic acid acts, is likely involved in promoting normal emotional behaviours. Current data suggest that the LPA-LPA1-receptor pathway may be involved in mediating the negative consequences of stress on hippocampal function. However, to date, there is no available information regarding the mechanisms whereby the LPA1 receptor mediates this adaptation. To gain further insight into how the LPA-LPA1 pathway may prevent the negative consequences of chronic stress, we assessed the effects of the continuous delivery of LPA on depressive-like behaviours induced by a chronic restraint stress protocol. Because a proper excitatory/inhibitory balance seems to be key for controlling the stress response system, the gene expression of molecular markers of excitatory and inhibitory neurotransmission was also determined. In addition, the hippocampal expression of mineralocorticoid receptor genes and glucocorticoid receptor genes and proteins as well as plasma corticosterone levels were determined. Contrary to our expectations, the continuous delivery of LPA in chronically stressed animals potentiated rather than inhibited some (e.g., anhedonia, reduced latency to the first immobility period), though not all, behavioural effects of stress. Furthermore, this treatment led to an alteration in the genes coding for proteins involved in the excitatory/inhibitory balance in the ventral hippocampus and to changes in corticosterone levels. In conclusion, the results of this study reinforce the assumption that LPA is involved in emotional regulation, mainly through the LPA1 receptor, and regulates the effects of stress on hippocampal gene expression and hippocampus-dependent behaviour.


Subject(s)
Behavior, Animal , Hippocampus/physiopathology , Receptors, Lysophosphatidic Acid/genetics , Stress, Psychological/genetics , Stress, Psychological/psychology , Anhedonia , Animals , Chronic Disease , Corticosterone/blood , Depression/psychology , Gene Expression , Male , Mice , Mice, Inbred C57BL , Neural Inhibition , Receptors, Mineralocorticoid/biosynthesis , Receptors, Mineralocorticoid/genetics , Stress, Psychological/physiopathology , Swimming/psychology , Synaptic Transmission
2.
Brain Struct Funct ; 219(5): 1659-72, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23775489

ABSTRACT

LPA1 receptor is one of the six characterized G protein-coupled receptors (LPA1-6) through which lysophosphatidic acid acts as an intercellular signaling molecule. It has been proposed that this receptor has a role in controlling anxiety-like behaviors and in the detrimental consequences of stress. Here, we sought to establish the involvement of the LPA1 receptor in emotional regulation. To this end, we examined fear extinction in LPA1-null mice, wild-type and LPA1 antagonist-treated animals. In LPA1-null mice we also characterized the morphology and GABAergic properties of the amygdala and the medial prefrontal cortex. Furthermore, the expression of c-Fos protein in the amygdala and the medial prefrontal cortex, and the corticosterone response following acute stress were examined in both genotypes. Our data indicated that the absence of the LPA1 receptor significantly inhibited fear extinction. Treatment of wild-type mice with the LPA1 antagonist Ki16425 mimicked the behavioral phenotype of LPA1-null mice, revealing that the LPA1 receptor was involved in extinction. Immunohistochemistry studies revealed a reduction in the number of neurons, GABA+ cells, calcium-binding proteins and the volume of the amygdala in LPA1-null mice. Following acute stress, LPA1-null mice showed increased corticosterone and c-Fos expression in the amygdala. In conclusion, LPA1 receptor is involved in emotional behaviors and in the anatomical integrity of the corticolimbic circuit, the deregulation of which may be a susceptibility factor for anxiety disorders and a potential therapeutic target for the treatment of these diseases.


Subject(s)
Emotions/physiology , Extinction, Psychological/physiology , Fear , Receptors, Lysophosphatidic Acid/metabolism , Stress, Psychological/metabolism , Amygdala/cytology , Animals , Conditioning, Classical , Corticosterone/metabolism , Corticosterone/pharmacology , Cues , Disease Models, Animal , Emotions/drug effects , Extinction, Psychological/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Isoxazoles/pharmacology , Lysophospholipids/pharmacology , Male , Mice , Mice, Knockout , Neurons/drug effects , Neurons/physiology , Phosphopyruvate Hydratase/metabolism , Propionates/pharmacology , Receptors, Lysophosphatidic Acid/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...